Taiwan FDA registration f44f12b6231f6ad66f18640b39edf120
bioMerieux Etest-Nitroimidazoles System
TW: 生物梅里埃易特試梯度條抗生素感受性檢測-硝基嘧唑類
Taiwan·Risk Class 2·MD·BIOMERIEUX SA·Registered May 26, 2016 – May 26, 2026ExpiredRegistration details
- Analysis ID
- f44f12b6231f6ad66f18640b39edf120
- License Form
- Ministry of Health Medical Device Import No. 028430
- Customs Code
- DHA05602843004
Company information
- Manufacturer
- BIOMERIEUX SA
- Manufacturer Country
- France
- Authorized Representative
- Hong Kong Commercial Mérieux S.p.A. Taiwan Branch
Product details
- Intended Use
- It is used to determine the drug susceptibility of anaerobic bacteria.
- Product Type (Level 1)
- C Immunology and microbiology devices
- Product Type (Level 2)
- C1640 Antimicrobial susceptibility test powder
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- May 26, 2016
- Expiry Date
- May 26, 2026
About this record
Access comprehensive regulatory information for bioMerieux Etest-Nitroimidazoles System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f44f12b6231f6ad66f18640b39edf120 and manufactured by BIOMERIEUX SA. The authorized representative in Taiwan is Hong Kong Commercial Mérieux S.p.A. Taiwan Branch.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices